EarlySense Monitoring Device Evaluation on COPD, CHF and Pneumonia Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00361426|
Recruitment Status : Withdrawn (No need)
First Posted : August 8, 2006
Last Update Posted : July 19, 2016
|Condition or disease||Intervention/treatment|
|COPD Patients||Device: Earlysense vital sign monitor|
Study's participants are CHF, COPD and Pneumonia patients or patients who are otherwise hospitalized in internal medicine department. During the study the patients' breathing patterns, heart rate, restlessness and cough in sleep will be measured by the EarlySense ES 16 device, which is placed in the patients' bed.
Patients' clinical status are followed. The patient's clinical condition is followed and analyzed in comparison to the EarlySense system output in order to determine the capability of the EarlySense system to predict COPD, CHF or Pneumonia deteriorations.
|Study Type :||Observational|
|Actual Enrollment :||0 participants|
|Observational Model:||Case Control|
|Official Title:||EarlySense Monitoring Device Evaluation on Patients in Med / Surg|
|Study Start Date :||January 2008|
|Actual Primary Completion Date :||February 2009|
|Actual Study Completion Date :||February 2009|
Device: Earlysense vital sign monitor
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00361426
|Chaim Sheba Medical Center|
|Ramat Gan, Israel|
|Principal Investigator:||Martine Szyper-Kravitz, M.D.||Haim Sheba Medical Center, Israel|